Verified Nov 2026
Electronics & Software
·
Minato, Tokyo
·
Since 1950
Fujirebio is a Japanese company headquartered in Minato, Tokyo, founded in 1950. It makes in vitro diagnostic reagents, instruments, and software for clinical and research testing, with a focus on neurology, oncology, and infectious diseases. It has an estimated 1,000 to 5,000 employees and an estimated annual revenue of $100 to $250 million. The company is privately held and serves automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2025 it acquired Plasma Services Group, adding biological raw material supply to the IVD and life science industries. In September 2026 it received Health Canada licenses for two blood-based neurology assays.
Fujirebio at a glance
Revenue
$100-250M
Est. band
Employees
1,000-5,000
Founded
1950
Headquarters
Minato, Tokyo
Certifications
ISO 13485 · ISO 9001
Import activity
25
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
25
Named foreign suppliers
7
Top origins
Germany · China · South Korea · Japan
Shared foreign counterparties do not establish that these companies buy from Fujirebio.
What this tells a buyer
Fujirebio announced in June 2025 its acquisition of Plasma Services Group, which expands its supply of biological raw materials to the IVD and life science industries.
The company holds ISO 13485 and ISO 9001 certifications and offers blood-based Alzheimer's biomarker tests, including Lumipulse assays cleared for use in Canada and Brazil.
Fujirebio is privately held, with an estimated 1,000 to 5,000 employees, and in February 2026 it began a sales collaboration with Sysmex for dementia testing.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & active
76 years in operation (founded 1950).
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
Fujirebio is a Japanese company headquartered in Minato, Tokyo, founded in 1950. It makes in vitro diagnostic reagents, instruments, and software for clinical and research testing, with a focus on neurology, oncology, and infectious diseases. It has an estimated 1,000 to 5,000 employees and an estimated annual revenue of $100 to $250 million. The company is privately held and serves automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2025 it acquired Plasma Services Group, adding biological raw material supply to the IVD and life science industries. In September 2026 it received Health Canada licenses for two blood-based neurology assays.
At a glance
Attribute | Detail |
|---|---|
Founded | 1950 |
Headquarters | Minato, Tokyo |
Employees | 1,000-5,000 |
Revenue | $100-250M (estimated) |
Primary capability | Electronics & Software |
Certifications | ISO 13485 · ISO 9001 |
What Fujirebio makes
The company holds ISO 13485 and ISO 9001 certifications and offers blood-based Alzheimer's biomarker tests, including Lumipulse assays cleared for use in Canada and Brazil.
Certifications
Fujirebio is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — fujirebio.com
ISO 9001 — fujirebio.com
Trade and customs footprint
Fujirebio announced in June 2025 its acquisition of Plasma Services Group, which expands its supply of biological raw materials to the IVD and life science industries. US customs bill-of-lading records list 25 inbound shipments across 7 foreign suppliers, with top origins including Germany · China · South Korea · Japan.
Latest developments
2026-09-14 — Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma | Fujirebio (fujirebio.com)
2026-09-01 — Fujirebio expands access in Canada to blood-based neurology testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma assays | Fujirebio (fujirebio.com)
2026-06-24 — Alzinova signs Letter of Intent with Fujirebio regarding potential commercialization of blood-based Alzheimer’s diagnostic test | Fujirebio (fujirebio.com)
2026-02-05 — Fujirebio and Sysmex begin sales collaboration for dementia testing | Fujirebio (fujirebio.com)
2025-06-23 — Fujirebio acquires Plasma Services Group and strengthens its position as provider of critical and high quality biological raw materials to the IVD and life science industries | Fujirebio (fujirebio.com)
2025-06-05 — Fujirebio announces strategic collaboration with Stanford Medicine to advance infectious disease research | Fujirebio (fujirebio.com)
Facilities
Fujirebio is headquartered in Minato, Tokyo. Public sources also reference these locations:
Moorestown, NJ — fujirebio.com
Company details
Fujirebio is privately held, with an estimated 1,000 to 5,000 employees, and in February 2026 it began a sales collaboration with Sysmex for dementia testing. Fujirebio was founded in 1950, has an estimated 1,000-5,000 employees, and is headquartered in Minato, Tokyo. On the LightSource stability read it is rated "Established & active": 76 years in operation (founded 1950). Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Fujirebio make?
Fujirebio is a Japanese company headquartered in Minato, Tokyo, founded in 1950. It makes in vitro diagnostic reagents, instruments, and software for clinical and research testing, with a focus on neurology, oncology, and infectious diseases. It has an estimated 1,000 to 5,000 employees and an estimated annual revenue of $100 to $250 million. The company is privately held and serves automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2025 it acquired Plasma Services Group, adding biological raw material supply to the IVD and life science industries. In September 2026 it received Health Canada licenses for two blood-based neurology assays.
Where is Fujirebio headquartered?
Fujirebio is headquartered in Minato, Tokyo.
When was Fujirebio founded?
Fujirebio was founded in 1950.
How big is Fujirebio?
Fujirebio has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).
What certifications does Fujirebio hold?
Fujirebio lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Fujirebio import from overseas suppliers?
US customs bill-of-lading records show 25 inbound shipments for Fujirebio, with top origins including Germany · China · South Korea · Japan.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.